10-Q: Xylem Inc. Reports Strong Q1 2024 Results Driven by Evoqua Acquisition and Organic Growth
Quarterly Report
Xylem Inc. saw a significant increase in revenue and earnings per share in the first quarter of 2024, boosted by the acquisition of Evoqua and solid organic growth.
Summary
- Xylem Inc. reported a 40.4% increase in revenue to $2.033 billion for the first quarter of 2024, compared to $1.448 billion in the same period last year.
- This growth was driven by a 7.1% organic increase and $480 million from acquisitions, primarily the acquisition of Evoqua Water Technologies Corp.
- Net income for the quarter was $153 million, or $0.63 per share, compared to $99 million, or $0.54 per share, in the first quarter of 2023.
- The company's order intake also saw a substantial increase of 43.1% to $2.246 billion, with a 3.4% organic increase.
- Adjusted EBITDA margin improved to 19.2%, up from 16.3% in the prior year.
- The company is updating its full year 2024 total revenue growth to be in the range of 15% to 16%, and organic revenue growth to be in the range of 4% to 6%.
Sentiment
Score: 8
Explanation: The document presents a very positive outlook with strong financial results, driven by a major acquisition and organic growth. While there are some challenges noted, the overall tone is optimistic and indicates a healthy business trajectory.
Positives
- Strong revenue growth driven by both acquisition and organic performance.
- Significant increase in order intake, indicating future revenue potential.
- Improved profitability with a higher adjusted EBITDA margin.
- Positive outlook for the remainder of 2024 with updated revenue growth guidance.
- The company has a strong backlog of $5.272 billion.
Negatives
- Gross margin decreased by 70 basis points to 37.0% due to increased costs and amortization.
- Applied Water segment revenue decreased by 3.8% due to softness in the U.S. and Western Europe.
- Restructuring costs of $9 million were incurred during the quarter, primarily due to the Evoqua acquisition.
- The company recognized a $1 million impairment charge for internally developed software.
Risks
- The company is exposed to fluctuations in foreign currency exchange rates.
- There are risks associated with the integration of the Evoqua acquisition.
- The company faces potential supply chain disruptions and cost increases.
- There is ongoing uncertainty related to a tax assessment in Sweden.
- The company is subject to various legal and regulatory proceedings.
Future Outlook
Xylem is updating its full year 2024 total revenue growth to be in the range of 15% to 16%, and organic revenue growth to be in the range of 4% to 6%.
Management Comments
- Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others.
- Management considers certain non-GAAP measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets.
Industry Context
The results reflect a strong demand environment for water technology solutions, with Xylem benefiting from its expanded portfolio following the Evoqua acquisition. The company's performance is also influenced by broader economic conditions, including inflation and supply chain dynamics.
Comparison to Industry Standards
- Xylem's revenue growth of 40.4% significantly exceeds the average growth rate for the water technology sector, which is typically in the single-digit range.
- The adjusted EBITDA margin of 19.2% is competitive with industry leaders, indicating strong operational efficiency.
- The company's backlog of $5.272 billion suggests a robust pipeline of future projects, which is a positive indicator compared to peers.
- Compared to companies like Danaher and IDEX, which also operate in related industrial sectors, Xylem's growth rate is higher, likely due to the recent acquisition.
- Xylem's performance in the Measurement and Control Solutions segment, with a 22.2% revenue increase, is notable compared to other companies in the smart metering space, such as Itron, which have seen more moderate growth.
Legal Proceedings
- The United States Attorneys Office for the District of Rhode Island is investigating whether financial misstatements were made in Evoquas public filings and earnings announcements.
- The company is involved in various legal and regulatory proceedings that are incidental to the operation of its businesses.
Stakeholder Impact
- Shareholders will benefit from the increased revenue, earnings, and share value.
- Employees may experience changes due to restructuring and integration efforts.
- Customers will have access to a broader range of products and services.
- Suppliers may see increased business opportunities due to the company's growth.
- Creditors will be reassured by the company's improved financial performance.
Next Steps
- The company will continue to integrate Evoqua into its operations.
- Xylem will focus on executing its strategic investments for growth.
- The company will monitor and manage its supply chain and cost structure.
- Xylem will continue to monitor and manage its global funding requirements.
Key Dates
| Date | Description |
|---|---|
| 2011-09-02 | Reference to the Five Year Revolving Credit Facility 2019 |
| 2015-08-24 | Board of Directors authorized the repurchase of up to $500 million in shares |
| 2016-10-11 | Issued 3.250% Senior Notes due 2026 and 4.375% Senior Notes due 2046 |
| 2019-03-05 | Xylem entered into a Five-Year Revolving Credit Facility (the 2019 Credit Facility) |
| 2019-06-03 | Xylem entered into a Euro commercial paper program |
| 2020-06-26 | Issued 1.950% Senior Notes due 2028 and 2.250% Senior Notes due 2031 (Green Bond) |
| 2023-03-01 | Xylem terminated the 2019 Credit Facility and entered into a five-year revolving credit facility (the 2023 Credit Facility) |
| 2023-05-09 | Xylem Europe GmbH entered into a twenty four-month 250 million term loan facility |
| 2023-05-24 | Xylem completed the acquisition of Evoqua Water Technologies Corp. |
| 2024-01-01 | Change to reportable segments effective |
| 2024-04-19 | Term Loan Facility was settled with cash on hand |
| 2024-04-26 | As of this date, there were 242,447,263 outstanding shares of the registrants common stock |
Keywords
Xylem, Evoqua, Water Technology, Water Infrastructure, Applied Water, Measurement and Control Solutions, Water Solutions and Services, Revenue Growth, Earnings Per Share, Acquisition, Organic Growth, EBITDA, Restructuring, Backlog
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.